Company profile for Pandion Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Pandion Therapeutics we are creating innovative modular proteins, antibodies and bispecifics precisely engineered to achieve lasting therapeutic outcomes for autoimmune and inflammatory diseases. We design and develop therapeutics with a modular approach to rebalance the immune system through differentiated mechanisms of action that can act systemically or locally. With our technology, know-how and drug development expertis...
At Pandion Therapeutics we are creating innovative modular proteins, antibodies and bispecifics precisely engineered to achieve lasting therapeutic outcomes for autoimmune and inflammatory diseases. We design and develop therapeutics with a modular approach to rebalance the immune system through differentiated mechanisms of action that can act systemically or locally. With our technology, know-how and drug development expertise, Pandion takes a unique combinatorial approach to developing immunomodulators that can be paired with tissue-selective tethers to create precisely engineered therapeutics.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
610 Main Street, Cambridge, MA 02139
Telephone
Telephone
(617) 393-5925
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/new-sec-charges-allege-insider-trading-related-mercks-acquisition-pandion-was-family-affair

Max Bayer FIERCEBIOTECH
11 Nov 2022

https://www.businesswire.com/news/home/20210401005471/en

BUSINESSWIRE
31 Mar 2021

https://www.contractpharma.com/contents/view_breaking-news/2021-03-16/selexis-pandion-enter-antibody-service-agreement/?widget=listSection

CONTRACTPHARMA
16 Mar 2021

https://www.businesswire.com/news/home/20210316005059/en

BUSINESSWIRE
16 Mar 2021

https://endpts.com/after-three-years-of-courtship-and-turndowns-merck-pounced-on-the-first-glance-of-clinical-data-in-1-85b-pandion-takeover/

Amber Tong ENDPTS
06 Mar 2021

https://www.fiercebiotech.com/biotech/pandion-s-secret-to-moving-a-65m-merck-offer-to-a-1-9b-done-deal-a-year-just-keep-saying-no

Ben Adams FIERCEBIOTECH
05 Mar 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty